JP2012102085A5 - - Google Patents

Download PDF

Info

Publication number
JP2012102085A5
JP2012102085A5 JP2011223557A JP2011223557A JP2012102085A5 JP 2012102085 A5 JP2012102085 A5 JP 2012102085A5 JP 2011223557 A JP2011223557 A JP 2011223557A JP 2011223557 A JP2011223557 A JP 2011223557A JP 2012102085 A5 JP2012102085 A5 JP 2012102085A5
Authority
JP
Japan
Prior art keywords
pharmaceutical composition
composition according
phosphodiesterase
inhibitor
herbal medicine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2011223557A
Other languages
English (en)
Japanese (ja)
Other versions
JP5809005B2 (ja
JP2012102085A (ja
Filing date
Publication date
Application filed filed Critical
Priority to JP2011223557A priority Critical patent/JP5809005B2/ja
Priority claimed from JP2011223557A external-priority patent/JP5809005B2/ja
Publication of JP2012102085A publication Critical patent/JP2012102085A/ja
Publication of JP2012102085A5 publication Critical patent/JP2012102085A5/ja
Application granted granted Critical
Publication of JP5809005B2 publication Critical patent/JP5809005B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2011223557A 2010-10-13 2011-10-11 Pde5阻害剤含有医薬組成物 Active JP5809005B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2011223557A JP5809005B2 (ja) 2010-10-13 2011-10-11 Pde5阻害剤含有医薬組成物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2010230163 2010-10-13
JP2010230163 2010-10-13
JP2011223557A JP5809005B2 (ja) 2010-10-13 2011-10-11 Pde5阻害剤含有医薬組成物

Publications (3)

Publication Number Publication Date
JP2012102085A JP2012102085A (ja) 2012-05-31
JP2012102085A5 true JP2012102085A5 (cg-RX-API-DMAC7.html) 2014-07-03
JP5809005B2 JP5809005B2 (ja) 2015-11-10

Family

ID=46392927

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2011223557A Active JP5809005B2 (ja) 2010-10-13 2011-10-11 Pde5阻害剤含有医薬組成物

Country Status (1)

Country Link
JP (1) JP5809005B2 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102768232B (zh) * 2012-06-29 2014-05-07 南京医科大学 一种西地那非分子印记膜电化学传感器的制备方法
JP7237998B2 (ja) * 2021-01-08 2023-03-13 小林製薬株式会社 ホスホジエステラーゼ5活性阻害用組成物

Similar Documents

Publication Publication Date Title
NZ713828A (en) Crystalline forms of a bruton’s tyrosine kinase inhibitor
EA201490014A1 (ru) Модифицированное высвобождение 4-метил-3-[[4-(3-пиридинил)-2-пиримидинил]амино]-n-[5-(4-метил-1h-имидазол-1-ил)-3-(трифторметил)фенил]бензамида, солюбилизированного с использованием органических кислот
WO2014027975A3 (en) Novel orally administered pharmaceutical formulations
JP2010518168A5 (cg-RX-API-DMAC7.html)
WO2016065226A8 (en) Indole carboxamides compounds useful as kinase inhibitors
JP2016518337A5 (cg-RX-API-DMAC7.html)
UA115320C2 (uk) Інгібітори кінази
EA201201509A1 (ru) Фармацевтические составы, содержащие пиоглитазон и линаглиптин
EA201792116A1 (ru) Ингибитор янус-киназы
MY194947A (en) Intranasal pharmaceutical dosage forms comprising naloxone
CL2013001136A1 (es) Un agente inhibitorio de la fosfodiesterasa 7 (pde7) para ser usado en el tratamiento o la reduccion de la posibilidad de una adiccion; y composicion farmaceutica, forma de dosificacion unitaria y kit farmaceutico que incluyen al inhibidor de fosfodiesterasa 7 (pde7) y un agente terapeutico adicional.
MX2016010179A (es) Composiciones de donepezilo y métodos para tratar la enfermedad de alzheimer.
EA201370230A1 (ru) Новые ингибиторы rock
CL2007000781A1 (es) Nanoparticulas que comprenden un inhibidor de quinasa de tirosina receptora del factor de crecimiento derivado de plaquetas; proceso de preparacion; composicion farmaceutica; y uso para el tratamiento de enfermedades vasculares, tales como restenosis
HRP20131233T1 (hr) Terapeutski sastav koji obuhvaä†a specifiäśni antagonist receptora endotelina i pde5-inhibitor
BRPI0816798A2 (pt) composto, composição farmacêutica, métodos para inibir a ação do glicogênio sintase cinase-3, e para tratar, prevenir ou melhorar uma doença, uso de um composto, e, artigo de fabricação
EP3162804A8 (en) New benzodiazepine derivative and use thereof
JP2017537912A5 (cg-RX-API-DMAC7.html)
WO2015173701A3 (en) Pharmaceutical compositions comprising danirixin for treating infectious diseases
FI3661510T3 (fi) Menetelmiä käyttäytymismuutosten hoitamiseksi
JP2016540030A5 (cg-RX-API-DMAC7.html)
WO2014027981A3 (en) Effervescent tablet formulations of dapoxetine and a pde5 inhibitor
PH12016500666A1 (en) Hydromorphone and naloxone for treatment of pain and opioid bowel dysfunction syndrome
JP2012102085A5 (cg-RX-API-DMAC7.html)
JP2010518167A5 (ja) 併存する早漏及び勃起障害を治療するための治療剤、製薬組成物及びキット